U.S. flag

An official website of the United States government

NM_000053.4(ATP7B):c.2975C>T (p.Pro992Leu) AND Inborn genetic diseases

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Sep 19, 2017
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002433726.2

Allele description [Variation Report for NM_000053.4(ATP7B):c.2975C>T (p.Pro992Leu)]

NM_000053.4(ATP7B):c.2975C>T (p.Pro992Leu)

Gene:
ATP7B:ATPase copper transporting beta [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
13q14.3
Genomic location:
Preferred name:
NM_000053.4(ATP7B):c.2975C>T (p.Pro992Leu)
HGVS:
  • NC_000013.11:g.51946369G>A
  • NG_008806.1:g.70126C>T
  • NM_000053.4:c.2975C>TMANE SELECT
  • NM_001005918.3:c.2354C>T
  • NM_001243182.2:c.2642C>T
  • NM_001330578.2:c.2741C>T
  • NM_001330579.2:c.2723C>T
  • NP_000044.2:p.Pro992Leu
  • NP_001005918.1:p.Pro785Leu
  • NP_001230111.1:p.Pro881Leu
  • NP_001317507.1:p.Pro914Leu
  • NP_001317508.1:p.Pro908Leu
  • NC_000013.10:g.52520505G>A
  • NM_000053.2:c.2975C>T
  • NM_000053.3:c.2975C>T
  • P35670:p.Pro992Leu
Protein change:
P785L
Links:
UniProtKB: P35670#VAR_000749; dbSNP: rs201038679
NCBI 1000 Genomes Browser:
rs201038679
Molecular consequence:
  • NM_000053.4:c.2975C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001005918.3:c.2354C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001243182.2:c.2642C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001330578.2:c.2741C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001330579.2:c.2723C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Inborn genetic diseases
Identifiers:
MeSH: D030342; MedGen: C0950123

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002751167Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Pathogenic
(Sep 19, 2017)
germlineclinical testing

PubMed (12)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

High prevalence of the H1069Q mutation in East German patients with Wilson disease: rapid detection of mutations by limited sequencing and phenotype-genotype analysis.

Caca K, Ferenci P, Kühn HJ, Polli C, Willgerodt H, Kunath B, Hermann W, Mössner J, Berr F.

J Hepatol. 2001 Nov;35(5):575-81.

PubMed [citation]
PMID:
11690702

Mutation analysis of 218 Chinese patients with Wilson disease revealed no correlation between the canine copper toxicosis gene MURR1 and Wilson disease.

Wu ZY, Zhao GX, Chen WJ, Wang N, Wan B, Lin MT, Murong SX, Yu L.

J Mol Med (Berl). 2006 May;84(5):438-42. Epub 2006 Jan 28.

PubMed [citation]
PMID:
16649058
See all PubMed Citations (12)

Details of each submission

From Ambry Genetics, SCV002751167.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (12)

Description

The p.P992L pathogenic mutation (also known as c.2975C>T), located in coding exon 13 of the ATP7B gene, results from a C to T substitution at nucleotide position 2975. The proline at codon 992 is replaced by leucine, an amino acid with similar properties. This mutation has been identified in multiple individuals with Wilson disease in the compound heterozygous or homozygous state (Nanji MS et al. Am. J. Hum. Genet., 1997 Jun;60:1423-9; Loudianos G et al. Hum. Mutat., 1998;12:89-94; Wu ZY et al. J. Mol. Med., 2006 May;84:438-42; Mak CM et al. J. Hum. Genet., 2008 Nov;53:55-63; Li K et al. J. Hum. Genet., 2013 Feb;58:67-72; Gu S et al. PLoS ONE, 2013 Jul;8:e66526). In addition, expression of this mutation in Sf9 cells showed partial copper uptake with normal phosphorylation activity (Huster D et al. Gastroenterology, 2012 Apr;142:947-956.e5). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 17, 2024